Celldex Therapeutics CLDX Software and Technology Licenses, Net
Software and Technology Licenses, Net at other companies
Other financials
Where this comes from
Reported directly by Celldex Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Celldex Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Celldex Therapeutics's software and technology licenses, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Celldex Therapeutics's software and technology licenses, net?
- Celldex Therapeutics (CLDX) reported software and technology licenses, net of $15.43M in Q1 2026.
- How has Celldex Therapeutics's software and technology licenses, net changed year-over-year?
- Celldex Therapeutics's software and technology licenses, net increased by 48.3% year-over-year, from $10.41M to $15.43M.
- What is the long-term trend for Celldex Therapeutics's software and technology licenses, net?
- Over 5 years (2020 to 2025), Celldex Therapeutics's software and technology licenses, net has grown at a 218.1% compound annual growth rate (CAGR), from $41K to $13.36M.